Serum antibodies againstSaccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma
✍ Scribed by Reinhold Ramoner; Andrea Rahm; Hubert Gander; Björn Stollenwerk; Claudia Falkensammer; Nicolai Leonhartsberger; Martin Thurnher
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 392 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Endostatin is the C‐terminal antiangiogenic fragment of the extracellular matrix protein collagen XVIII, and is generated by tumor‐derived proteases. The presence of serum endostatin in patients with gastric cancer has not been reported. The authors assessed the serum levels of endostat
## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi